NCT05507463View on ClinicalTrials.gov

Study of KBP-7072 in Healthy Male and Female Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

56

Participants

Timeline

Start Date

August 16, 2022

Primary Completion Date

June 29, 2023

Study Completion Date

June 29, 2023

Conditions

Healthy Subjects

Interventions

DRUG

KBP-7072

KBP-7072

DRUG

Placebo

Placebo

Trial Locations (1)

21225

Parexel International - Early Phase Clinical Unit, Baltimore

Sponsors

Lead Sponsor

KBP Biosciences

Collaborators (1)

All Listed Sponsors

collaborator

Parexel

INDUSTRY

lead

KBP Biosciences

INDUSTRY

NCT05507463 - Study of KBP-7072 in Healthy Male and Female Subjects | Biotech Hunter | Biotech Hunter